메뉴 건너뛰기
Journal of Drugs in Dermatology
Volumn 7, Issue 11, 2008, Pages 1089-1093
Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy
Author keywords

[No Author keywords available]
Indexed keywords

ANTIRHEUMATIC AGENT; EFALIZUMAB; IMMUNOGLOBULIN G; INFLIXIMAB; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;
EID: 58749099962     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)
References (8)
  • 1
    • 33645705227 scopus 로고    scopus 로고
    • Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: Today and tomorrow
    • Pelletier JP, Martel-Pelletier J, Raynauld JP. Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow. Arthritis Res Ther. 2006;8:206.
    • (2006) Arthritis Res Ther , vol.8 , pp. 206
    • Pelletier, J.P.1    Martel-Pelletier, J.2    Raynauld, J.P.3
  • 2
    • 25844490095 scopus 로고    scopus 로고
    • Epidemiology of psoriatic arthritis in the population of the United States
    • Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53:573.
    • (2005) J Am Acad Dermatol , vol.53 , pp. 573
    • Gelfand, J.M.1    Gladman, D.D.2    Mease, P.J.3
  • 3
    • 0034104357 scopus 로고    scopus 로고
    • The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991
    • Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol. 2000;27:1247-1250.
    • (2000) J Rheumatol , vol.27 , pp. 1247-1250
    • Shbeeb, M.1    Uramoto, K.M.2    Gibson, L.E.3
  • 4
    • 0035986559 scopus 로고    scopus 로고
    • Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study
    • Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol. 2002;82:108-113.
    • (2002) Acta Derm Venereol , vol.82 , pp. 108-113
    • Zachariae, H.1    Zachariae, R.2    Blomqvist, K.3
  • 5
    • 33749864120 scopus 로고    scopus 로고
    • package insert. South San Francisco, CA: Genentech, Inc.; June
    • Raptiva® (efalizumab) [package insert]. South San Francisco, CA: Genentech, Inc.; June 2005.
    • (2005) Raptiva® (Efalizumab)
  • 6
    • 2942523943 scopus 로고    scopus 로고
    • T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): Mechanisms of action
    • DOI 10.1159/000077660
    • Jullien D, Prinz JC, Langley RG, et al. T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action. Dermatology. 2004;208:297-306. (Pubitemid 38736650)
    • (2004) Dermatology , vol.208 , Issue.4 , pp. 297-306
    • Jullien, D.1    Prinz, J.C.2    Langley, R.G.B.3    Caro, I.4    Dummer, W.5    Joshi, A.6    Dedrick, R.7    Natta, P.8
  • 7
    • 27544468158 scopus 로고    scopus 로고
    • prescribing information. Thousand Oaks, CA: Immunex Corporation; April
    • Enbrel® (etanercept) [prescribing information]. Thousand Oaks, CA: Immunex Corporation; April 2006.
    • (2006) Enbrel® (Etanercept)
  • 8
    • 0345961813 scopus 로고    scopus 로고
    • prescribing information. Malvern, PA: Centocor, Inc.; April
    • Remicade® (infliximab) for IV injection [prescribing information]. Malvern, PA: Centocor, Inc.; April 2007.
    • (2007) Remicade® (Infliximab) for IV Injection

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.